152 related articles for article (PubMed ID: 6208857)
1. Thoracotomy as a staging procedure after chemotherapy in the treatment of Stage III nonseminomatous carcinoma of the testis.
Prenger K; Eysman L; van der Heide JN; Oldhoff J; Sleijfer DT; Koops HS; Oosterhuis JW
Ann Thorac Surg; 1984 Nov; 38(5):444-6. PubMed ID: 6208857
[TBL] [Abstract][Full Text] [Related]
2. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
3. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
4. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
5. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
6. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
7. Treatment of nonseminomatous testicular tumor with minimal retroperitoneal lymph node involvement.
Pontes JE
Prog Clin Biol Res; 1985; 203():579-83. PubMed ID: 2421343
[No Abstract] [Full Text] [Related]
8. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
9. Lymphadenectomy for testicular carcinoma.
Laplante MP; Mount BM
Can J Surg; 1982 May; 25(3):262-6. PubMed ID: 6177391
[TBL] [Abstract][Full Text] [Related]
10. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
[TBL] [Abstract][Full Text] [Related]
11. [Case of testicular cancer with malignant transformation in the residual retroperitoneal mature teratoma 8 years after the initial chemotherapy].
Ito K; Iigaya T; Umezawa A
Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):622-6. PubMed ID: 9666691
[TBL] [Abstract][Full Text] [Related]
12. Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis. No evidence for De Novo induction of differentiation.
Oosterhuis JW; Suurmeyer AJ; Sleyfer DT; Koops HS; Oldhoff J; Fleuren G
Cancer; 1983 Feb; 51(3):408-16. PubMed ID: 6185202
[TBL] [Abstract][Full Text] [Related]
13. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
14. Postchemotherapy surgery in nonseminomatous testicular tumors.
Hornák M; Ondrus D; Matoska J; Cársky S
Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
[TBL] [Abstract][Full Text] [Related]
15. [Lung residuals following chemotherapy in patients with stage III nonseminomatous testicular cancer. Report of 4 cases].
Ueda T; Yamauchi T; Kawai T; Ohno Y; Kawakami S; Yonese J; Tachibana Y
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):350-3. PubMed ID: 7509890
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors.
Scardino PT
Urol Clin North Am; 1980 Oct; 7(3):735-45. PubMed ID: 6161463
[No Abstract] [Full Text] [Related]
17. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
18. Recurrent testis cancer: seeding from retroperitoneal nodes after complete remissions by chemotherapy.
Kamer M; Rowland RG; Einhorn LH; Donohue JP
J Urol; 1983 Dec; 130(6):1196-8. PubMed ID: 6196491
[TBL] [Abstract][Full Text] [Related]
19. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
[TBL] [Abstract][Full Text] [Related]
20. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
